[go: up one dir, main page]

Werner et al., 1941 - Google Patents

A quantitative study of the urinary excretion of hypophyseal gonadotropin, estrogen, and androgen of normal women

Werner et al., 1941

View PDF
Document ID
9492630762946135283
Author
Werner S
et al.
Publication year
Publication venue
The Journal of Clinical Investigation

External Links

Snippet

METHOD All urine specimens were complete forty-eight-hour collections kept in tightly stoppered bottles containing 10 cc. of chloroform for a day's output. The specimens were kept in the cold during collectionin most instances. The urine was then placed in the ice …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Similar Documents

Publication Publication Date Title
Werner A quantitative study of the urinary excretion of hypophyseal gonadotropin, estrogen, and androgen of normal women
Levin et al. The quantitative assay of “follicle stimulating” substances
Oakey et al. The rapid estimation of oestrogens in pregnancy to monitor foetal risk
Johnsen A clinical routine-method for the quantitative determination of gonadotrophins in 24-hour urine samples, II: Normal values for men and women at all age groups from pre-puberty to senescence
Kennedy et al. The post-natal development of the ovary and uterus of the Merino lamb
Kulin et al. Gonadotropins during childhood and adolescence: a review
Jailer A fluorometric method for the clinical determination of estrone and estradiol
Katagiri et al. Estriol in pregnancy: IV. Normal concentrations, diurnal and/or episodic variations, and day-to-day changes of unconjugated and total estriol in late pregnancy plasma
Wallace et al. Menstrual cycle patterns and breast cancer risk factors
Smith et al. The quantitative determination of urinary oestrin
EBERLEIN et al. A simplified method for the routine measurement of urinary estriol
Zondek et al. PGlycogen content of the human uterine mucosa glycopenia uteri
BROWN et al. CURRENT STATUS OF ESTROGEN ASSAY IN GYNECOLOGY AND OBSTETRICS: Part I. Estrogen Assays in Gynecology and Early Pregnancy
Witschi THE QUANTITATIVE DETERMINATION OF FOLLICLE STIMULATING AND LUTEINIZING HORMONES IN MAMMALIAN PITUITARIES AND A DISCUSSION OF THE GONADOTROPIC QUOTIENT, F⁄ L
Diczfalusy et al. Some factors influencing the estimation of urinary 17-ketogenic steroids
Cope Diagnostic Value of Pregnandiol Excretion in Pregnancy Disorders
Cuthbertson et al. The fate of tocopherols in the animal body
Furuhjelm On The Excretion of Oestrogenic and Androgenic Substances in the Urine of Women: An Investigation Covering Fourteen Healthy Women, Ten Cases of Myoma and Two of Castration
RUBENSTEIN et al. A technic for assay of estrogen by evaluation of human vaginal smears and comparison with urinary estrogen assay on the mouse uterus
Hoffman Studies in the metabolism of progesterone
Doran et al. Amniotic fluid lecithin/sphingomyelin ratio, palmitic acid, palmitic acid/stearic acid ratio, total cortisol, creatinine, and percentage of lipid-positive cells in assessment of fetal maturity and fetal pulmonary maturity: a comparison
KLOPPER Pregnanediol and pregnanetriol
SMITH et al. FACTORS INFLUENCING THE COMPOSITION OF THE SODIUM “PREGNANEDIOL” GLUCURONIDE COMPLEX IN HUMAN PREGNANCY, WITH ESPECIAL REFERENCE TO DIETHYLSTILBESTROL THERAPY
Hain Œstrogenic and Androgenic Substances in Pregnancy
Smith The quantitative determination of urinary pregnanediol in pregnant women: the influence of the method upon results